Kevin M Pantalone

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Diabetes Care 33:1224-9. 2010
  2. doi Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System
    Kevin M Pantalone
    Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, OH
    Diabetes Care 39:1527-34. 2016
  3. doi Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report
    Kevin M Pantalone
    Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Diabetes Technol Ther 15:342-3. 2013
  4. doi Male hypogonadism: more than just a low testosterone
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:717-25. 2012
  5. doi The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
    Kevin M Pantalone
    Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue NA10, Cleveland, OH, 44195, USA
    Acta Diabetol 46:145-54. 2009
  6. doi Approach to a low TSH level: patience is a virtue
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:803-11. 2010
  7. doi Insulin glargine use during pregnancy
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA
    Endocr Pract 17:448-55. 2011
  8. pmc Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013
    Kevin M Pantalone
    Endocrinology, Cleveland Clinic, Cleveland, OH, USA
    Clin Med Insights Endocrinol Diabetes 9:23-30. 2016

Detail Information

Publications8

  1. pmc The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Diabetes Care 33:1224-9. 2010
    ..The purpose of this study was to assess the relationship of individual sulfonylureas and the risk of overall mortality in a large cohort of patients with type 2 diabetes...
  2. doi Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System
    Kevin M Pantalone
    Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, OH
    Diabetes Care 39:1527-34. 2016
    ..This project evaluated the intensification of diabetes therapy and hemoglobin A1c (A1C) goal attainment among patients with newly diagnosed type 2 diabetes when metformin monotherapy failed...
  3. doi Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report
    Kevin M Pantalone
    Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Diabetes Technol Ther 15:342-3. 2013
    ..We describe the effectiveness of liraglutide therapy in a severely insulin-resistant patient with type 2 diabetes mellitus (DM-2) requiring U-500 insulin...
  4. doi Male hypogonadism: more than just a low testosterone
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:717-25. 2012
    ....
  5. doi The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
    Kevin M Pantalone
    Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue NA10, Cleveland, OH, 44195, USA
    Acta Diabetol 46:145-54. 2009
    ..In conclusions, our results did not identify an increased CAD risk with rosiglitazone in clinical practice. However, the results do reinforce a possible increased risk of adverse events in DM2 patients prescribed sulfonylureas...
  6. doi Approach to a low TSH level: patience is a virtue
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:803-11. 2010
    ....
  7. doi Insulin glargine use during pregnancy
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA
    Endocr Pract 17:448-55. 2011
    ..To review the literature regarding the use of insulin glargine during pregnancy, specifically addressing the issues and concerns surrounding mitogenicity, placental transfer, and maternal and fetal safety...
  8. pmc Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013
    Kevin M Pantalone
    Endocrinology, Cleveland Clinic, Cleveland, OH, USA
    Clin Med Insights Endocrinol Diabetes 9:23-30. 2016
    ..Metformin was the most commonly prescribed antidiabetic medication. Sulfonylurea usage remained unchanged, while use of thiazolidinediones decreased considerably. ..